Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sentage Holdings (SNTG) Current Deferred Revenue (2020 - 2025)

Sentage Holdings has reported Current Deferred Revenue over the past 4 years, most recently at $23410.0 for Q4 2023.

  • Quarterly Current Deferred Revenue rose 13.68% to $23410.0 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $23410.0 through Dec 2023, up 13.68% year-over-year, with the annual reading at $23410.0 for FY2023, 13.68% up from the prior year.
  • Current Deferred Revenue was $23410.0 for Q4 2023 at Sentage Holdings, up from $20592.0 in the prior quarter.
  • Over five years, Current Deferred Revenue peaked at $154106.0 in Q4 2020 and troughed at $20592.0 in Q4 2022.
  • The 4-year median for Current Deferred Revenue is $30881.5 (2021), against an average of $59115.2.
  • The largest YoY upside for Current Deferred Revenue was 13.68% in 2023 against a maximum downside of 13.68% in 2023.
  • A 4-year view of Current Deferred Revenue shows it stood at $154106.0 in 2020, then crashed by 75.11% to $38353.0 in 2021, then tumbled by 46.31% to $20592.0 in 2022, then increased by 13.68% to $23410.0 in 2023.
  • Per Business Quant, the three most recent readings for SNTG's Current Deferred Revenue are $23410.0 (Q4 2023), $20592.0 (Q4 2022), and $38353.0 (Q2 2021).